With around 90% of companies now ‘in the cloud’, the industry has become a driving force behind global technology infrastructure and service delivery. While this has offered major benefits to the entire European economy, the market dominance of US-based hyperscale cloud providers has raised concerns among EU leaders.
Between them, AWS, Microsoft Azure and Google Cloud account for over 53% of worldwide cloud infrastructure spend, according to Canalys. European cloud hosting providers, in contrast, lag significantly behind, even in their domestic markets. As Synergy Research Groups puts it, “Behind the top two the battle is being played out between Google, IBM, other smaller global cloud providers and some major local telcos and IT service providers.”
Cloud is the ideal solution for today’s unpredictable business environment. From supporting remote working to enabling organisations to get new applications to market quickly, it’s helped many survive and even thrive in recent months.
However, while the headline costs of cloud are appealing, there are hidden traps which have led to problems and overspend for many organisations. Once you have got rid of your in-house infrastructure, you have to rely on what the cloud provider offers. Portability between providers is not yet proven, and it is not in a provider’s interests to make it easy! Based on our experience, we’ve identified four areas to review to ensure you control your cloud services, rather than letting them control you.
One of the lessons – and there are many – to come out of the current global public health crisis is the importance of adaptability.
A common manifestation of this trait is in the ever-growing remote workplace, the adoption of which has changed business infrastructure as we knew it—and the ecosystem for Managed Service Providers (MSPs) is no different.
Google Cloud is launching a new suite of security-focused products to persuade cloud-shy organisations to migrate sensitive data to the cloud.
Heavily regulated industries such as financial, insurance, or pharmaceutical firms have been reluctant to go all-in on cloud due to strict security and compliance requirements about how sensitive data is stored.